.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Medtronic
Fuji
Teva
Johnson and Johnson
Fish and Richardson
Novartis
UBS
Merck

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072264

« Back to Dashboard
NDA 072264 describes BENZTROPINE MESYLATE, which is a drug marketed by Usl Pharma, Oxford Pharms, Quantum Pharmics, Aspen Global Inc, Vintage, Navinta Llc, Fresenius Kabi Usa, Luitpold, Pliva, Epic Pharma Llc, Frontida Biopharm, Leading Pharma Llc, Lannett Holdings Inc, Hikma Farmaceutica, and Invagen Pharms, and is included in twenty-seven NDAs. It is available from thirty suppliers. Additional details are available on the BENZTROPINE MESYLATE profile page.

The generic ingredient in BENZTROPINE MESYLATE is benztropine mesylate. There are five drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.

Summary for NDA: 072264

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 072264

Suppliers and Packaging for NDA: 072264

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL 072264 ANDA Major Pharmaceuticals 0904-1055 0904-1055-61 100 TABLET in 1 BOX, UNIT-DOSE (0904-1055-61)
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL 072264 ANDA Cardinal Health 55154-1347 55154-1347-0 10 BLISTER PACK in 1 BAG (55154-1347-0) > 1 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Feb 27, 1989TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
US Army
Deloitte
QuintilesIMS
Julphar
Cerilliant
Queensland Health
Harvard Business School
Farmers Insurance
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot